Publication: Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss
3
Issued Date
2020-11-01
Resource Type
ISSN
15346293
15284042
15284042
Other identifier(s)
2-s2.0-85090905615
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Current Neurology and Neuroscience Reports. Vol.20, No.11 (2020)
Suggested Citation
Tanyatuth Padungkiatsagul, Loh Shan Leung, Heather E. Moss Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss. Current Neurology and Neuroscience Reports. Vol.20, No.11 (2020). doi:10.1007/s11910-020-01071-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/59139
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss
Other Contributor(s)
Abstract
© 2020, Springer Science+Business Media, LLC, part of Springer Nature. Purpose of Review: This review aims to discuss retinal diseases that may masquerade as neurological causes of vision loss and highlights modern ophthalmic ancillary testing that can help to establish these diagnoses. Recent Findings: Retinal diseases with signs and symptoms overlapping with neurological causes of vision loss include central serous chorioretinopathy, retinal ischemia, acute macular neuroretinopathy, Acute zonal occult outer retinopathy (AZOOR) complex diseases, paraneoplastic retinopathy, retinal dystrophy, and toxic retinopathy. Diagnosis is facilitated by electrophysiologic studies and multimodal ophthalmic imaging including optical coherence tomography and fundus autofluorescence imaging. Looking into the future, translation of adaptive optics ophthalmoscopy into clinical practice may facilitate early detection of microscopic retinal abnormalities that characterize these conditions. Summary: With conventional methods of physical examination, diagnosis of retinal diseases that may masquerade as neurological causes of vision loss can be challenging. Current advance in multimodal ophthalmic imaging along with electrophysiologic studies enhances the provider’s ability to make early diagnosis and monitor progression of these conditions.